Načítá se...
Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline
OBJECTIVE: To determine the effect of low-dose aspirin vs placebo on incident all-cause dementia, incident Alzheimer disease (AD), mild cognitive impairment (MCI), and cognitive decline in older individuals. METHODS: Aspirin in Reducing Events in the Elderly (ASPREE) was a double-blind, placebo-cont...
Uloženo v:
| Vydáno v: | Neurology |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Lippincott Williams & Wilkins
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7455352/ https://ncbi.nlm.nih.gov/pubmed/32213642 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000009277 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|